Craft
Bactiguard

Bactiguard

Revenue

KR169.5 M

FY, 2021

Market Capitalization

KR3.6 B

2023-01-27

Bactiguard Summary

Company summary

Overview
Bactiguard, a medtech company, develops and provides infection prevention solutions. Its products include bactiguard infection protection (BIP) foley catheter, an indwelling urinary catheter used for drainage and irrigation of the bladder, or for the collection and measurement of patient urine; BIP central venous catheters that administer medication and intravenous solutions, measures pressure, and collects blood samples; and BIP endotracheal tube for use in airway management by oral or nasal intubation of the trachea.
Type
Public
Status
Active
Founded
2005
HQ
Botkyrka, SE | view all locations
Website
https://www.bactiguard.se/en
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Botkyrka, Stockholm County HQ

    Sweden

    Tullinge

Bactiguard Financials

Summary financials

Revenue (Q3, 2022)
kr66.2M
Gross profit (Q3, 2022)
kr54.7M
Net income (Q3, 2022)
(kr8.5M)
Cash (Q3, 2022)
kr204.8M
EBIT (Q3, 2022)
(kr11.0M)
Enterprise value
$3.7B

Footer menu